← Leaderboards
Sandra M. Garraway
Emory University
$2,787,784
Attributed
$2,787,784
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $811.8K · FY2013–22$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,787,784 · 3
By mechanism
R01$1,931,623 · 1
R21$856,161 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationPainful NeuropathyPeripheralClinically RelevantMediatingPainSpinalPlaySignal TransductionChronic Neuropathic PainSpinal Cord InjuryMolecularBehavioralCentral SensitizationAllodyniaMediator Of Activation ProteinAdultLeadMechanical AllodyniaInjuryInvestigationContusionsMechanoreceptorsCutaneous
Grant awards (8)
Examining the roles A-delta LTMRs and BDNF signaling play in neuropathic pain after SCI$386,582
R01 · FY2022 · NS · contact PI
Examining the roles A-delta LTMRs and BDNF signaling play in neuropathic pain after SCI$386,582
R01 · FY2021 · NS · contact PI
Peripheral BDNF drives primary afferent hyperexcitability and pain hypersensitivity$425,189
R21 · FY2020 · NS · contact PI
Examining the roles A-delta LTMRs and BDNF signaling play in neuropathic pain after SCI$386,582
R01 · FY2020 · NS · contact PI
Examining the roles A-delta LTMRs and BDNF signaling play in neuropathic pain after SCI$386,582
R01 · FY2019 · NS · contact PI
Examining the roles A-delta LTMRs and BDNF signaling play in neuropathic pain after SCI$385,295
R01 · FY2018 · NS · contact PI
Interaction between SCI and Noxious Input: Modulation of Pain Hypersensitivity$188,521
R21 · FY2014 · NS · contact PI
Interaction between SCI and Noxious Input: Modulation of Pain Hypersensitivity$242,451
R21 · FY2013 · NS · contact PI